Memorial Sloan Kettering Cancer Center
1275 York Avenue
New York
New York
10065
United States
203 articles about Memorial Sloan Kettering Cancer Center
-
This morning, multiple companies announced clinical and strategic collaborations to develop novel therapies and treatments for various diseases. Here are some of them.
-
Dr. Dennis Gross Donates $100,000 to World-Renowned Cancer Center to Support Skin Cancer Research
6/8/2021
Dr. Dennis Gross Skincare announces a donation to Memorial Sloan Kettering Cancer Center, pledging a $100,000 contribution to fund melanoma fellowships with the goal to develop more effective strategies for detecting, preventing, controlling and, ultimately, curing skin cancer.
-
Companies have already begun their announcements of new clinical studies for various treatment settings in preparation for ASCO 2021.
-
How a bad day at work led to better COVID predictions
5/4/2021
Talking about your bad day at work could lead to great solutions. Cold Spring Harbor Laboratory Associate Professor Saket Navlakha and his wife, Dr. Sejal Morjaria, an infectious disease physician at Memorial Sloan Kettering Cancer Center, found a way to predict COVID-19 severity in cancer patients.
-
Candel Therapeutics Announces Formation of New Research Advisory Board Comprised of Multiple Prominent Scientists and Clinicians including 2018 Nobel Laureate, James Allison, Ph.D.
4/13/2021
Candel Therapeutics, a clinical-stage biotechnology company developing novel immune-based cancer therapeutics, announced the initial formation of its Research Advisory Board with the appointment of James Allison, Ph.D., Henry Brem, M.D., Roy S. Herbst, M.D., Ph.D., Elizabeth Jaffee, M.D., Philip Kantoff, M.D., and Padmanee Sharma, M.D., Ph.D., who will join existing scientific advisor and board member Edward Benz, M.D.
-
New research out of the Memorial Sloan Kettering Cancer Center suggests the genetically engineered immune cells can be used to treat diseases of senescence, which could include fibrotic liver disease, atherosclerosis, and diabetes.
-
Memorial Sloan Kettering - Hackensack Meridian Health Partnership Announces Funding for Inaugural Immunology Research Collaboration Projects
6/5/2020
Three immunology projects will explore the creation of cancer-targeted T-cells within the thymus, and the impact of gut microbiota in patients with multiple myeloma and other cancers including those receiving stem cell transplantation [05-June-2020] HACKENSACK, N.J. and NEW YORK , June 5, 2020 /PRNewswire/ -- As part of the Memorial Sloan Kettering – Hackensack Meri
-
Rising Pharmaceuticals & Laurus Labs to Support a Phase 2 Randomized Clinical Trial of Hydroxychloroquine for Prophylaxis Against COVID-19 in Patients Receiving Cancer Therapy
5/7/2020
Trial conducted at Memorial Sloan Kettering Cancer Center designed to evaluate potential risk reduction for patients at risk for coronavirus infection
-
Memorial Sloan Kettering Selects NeuroLogica Mobile CT for Brachytherapy Imaging
1/7/2020
Prestigious Cancer Center Deploys NeuroLogica BodyTom in Radiation Oncology to Help Enhance Therapy Precision
-
Enterome enters research collaboration with major cancer center focused on new microbiome-derived immunotherapies
11/7/2019
Collaboration aims to evaluate the potential of microbiome-derived antigens that mimic tumor antigens and neoantigens ("onco-mimics") to induce anti-tumor immune responses
-
Enterome and Memorial Sloan Kettering Cancer Center have teamed up to evaluate the potential of gut microbiome-derived antigens for development as potential cancer immunotherapies.
-
New York's First Proton Therapy Center Begins Treating Patients
9/10/2019
The New York Proton Center's hospital partners--Memorial Sloan Kettering Cancer Center, Montefiore Health System and Mount Sinai Health System--have begun treating patients at the new state-of-the-art facility in East Harlem
-
Varian-equipped New York Proton Therapy Center Treats First Patients
9/10/2019
NYPC is expected to treat 1,400 patients annually, including most children in New York City with solid tumors, delivering the most advanced form of cancer radiation treatment currently available.
-
Hyundai Hope On Wheels Presents Memorial Sloan Kettering Cancer Center With Hyundai Young Investigator & Scholar Hope Grant Totaling $500,000 To Support Pediatric Cancer Research
9/5/2019
The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this September during Childhood Cancer Awareness Month to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research.
-
Krishnan Suthanthiran, President & Founder of TeamBest Companies & Best Cure Foundation, Presents the AAPM Best Award to its 2019 Recipients in San Antonio, Texas, at the AAPM Annual Meeting
7/15/2019
On July 15th, Krishnan Suthanthiran, President & Founder of TeamBest Companies and Best Cure Foundation, presented the AAPM Best Award to the 2019 recipients at the Annual Meeting of the American Association of Physicists in Medicine taking place in San Antonio, Texas, USA July 14–17, 2019.
-
Connexient Launches MSKcompass - Indoor GPS App to Help Patients and Visitors Find Their Way From Home to Appointment
7/2/2019
Connexient announced that its new, mobile-based GPS-like application, MSKcompass, is live and available for download by patients and visitors at Memorial Sloan Kettering Cancer Center's Westchester location.
-
MORE Health Announces Strategic Collaboration with Memorial Sloan Kettering Cancer Center
6/13/2019
Memorial Sloan Kettering Cancer Center is the world's oldest and largest private cancer center
-
Origenis GmbH Announces Research Collaboration with U.S. Cancer Center
6/4/2019
Origenis AI Discovery Platform to Identify and Optimize Small Molecule Preclinical Development Candidates for Glioblastoma
-
Independent Review Shows Memorial Sloan Kettering Leaders Repeatedly Violated Conflict of Interes...
4/5/2019
A review of top officials at Memorial Sloan Kettering Cancer Center found that there were repeated violations on financial conflicts of interest. The review was conducted by law firm Debevoise & Plimpton and jointly reported by The New York Times and ProPublica. -
DeGregorio Family Foundation Awards Grant to Sam Yoon of Memorial Sloan Kettering Cancer Center and Sandra Ryeom of University of Pennsylvania Perelman School of Medicine
3/5/2019
This award will support Dr. Yoon's research on establishing a deeper understanding of how gastric cancer stem-like cells lead to distant metastasis and resistance to chemotherapy regimens.